Ajer Jeffrey Robert
SEC CIK 1557533 · EDGAR
BoughtSold
Most active insiders at BMRN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Davis George Eric | EVP, CLO | — | $2.76M |
| 2 | Guyer Charles Greg | EVP, Chief Technical Off | — | $996.7K |
| 3 | Friberg Gregory R | EVP, Chief R, D Off | — | $558.6K |
| 4 | Ramchandani Rashmi Virendra | VP, CAO | — | — |
| 5 | Hubbard Cristin | EVP, Chief Commercial Off | — | — |
| 6 | Hardy Alexander | CEO, Dir | — | — |
| 7 | Plenge Robert M | Dir | — | — |
| 8 | ANDERSON ELIZABETH M | Dir | — | — |
| 9 | Bodem Barbara W. | Dir | — | — |
| 10 | Ho Maykin | Dir | — | — |
Ajer Jeffrey Robert made no open-market trades at BMRN in the last 12 months.
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-06 | 2024-04-30 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | A - Grant | $68.65 | +300 | 71.8K | +0.4% | +$20.6K | |
| 2024-05-06 | 2024-05-02 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | S - Sale | $82.91 | -5,000 | 66.8K | -7% | -$414.6K | |
| 2024-03-19 | 2024-03-15 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | F - Tax | $83.87 | -22.6K | 71.5K | -24% | -$1.89M | |
| 2024-03-07 | 2024-03-05 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | S - Sale | $87.07 | -4,000 | 94.0K | -4% | -$348.3K | |
| M | 2024-02-29 | 2024-02-27 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | A - Grant | $0.00 | +37.2K | 82.2K | +83% | $0 |
| D | 2023-09-20 | 2023-09-18 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Dir | S - Sale | $0.69 | -4,359 | 34.2K | -11% | -$3,008 |
| 2023-08-17 | 2023-08-16 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | S - Sale | $90.00 | -5,000 | 60.8K | -8% | -$450.0K | |
| 2023-08-17 | 2023-04-28 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | A - Grant | $66.88 | +318 | 65.8K | +0.5% | +$21.3K | |
| D | 2023-03-17 | 2023-03-15 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | A - Grant | $0.00 | +10.1K | 90.0K | +13% | $0 |
| DM | 2023-03-17 | 2023-03-15+ | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | F - Tax | $92.49 | -24.5K | 65.5K | -27% | -$2.26M |
| M | 2023-03-02 | 2023-02-28 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | A - Grant | $0.00 | +38.8K | 79.9K | +94% | $0 |
| DM | 2023-01-27 | 2023-01-25 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | S - Sale+OE | $115.69 | -49.0K | 45.3K | -52% | -$5.67M |
| D | 2023-01-27 | 2023-01-25 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | M - OptEx | $67.81 | +49.0K | 90.1K | +119% | +$3.32M |
| 2022-11-04 | 2022-11-02 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | S - Sale | $86.12 | -3,000 | 41.1K | -7% | -$258.4K | |
| 2022-09-26 | 2022-09-23 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Dir | S - Sale | $3.16 | -4,198 | 38.5K | -10% | -$13.3K | |
| D | 2022-09-20 | 2022-09-16 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Dir | A - Grant | $0.00 | +10.2K | 42.7K | +31% | $0 |
| 2022-08-12 | 2022-08-11 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | S - Sale | $95.62 | -3,000 | 44.1K | -6% | -$286.9K | |
| 2022-06-07 | 2022-06-03 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | F - Tax | $77.49 | -7,021 | 47.1K | -13% | -$544.1K | |
| 2022-05-31 | 2022-04-29 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | A - Grant | $62.41 | +340 | 55.4K | +0.6% | +$21.2K | |
| 2022-05-31 | 2022-05-26 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | S - Sale | $78.94 | -1,308 | 54.1K | -2% | -$103.3K | |
| 2022-04-14 | 2022-04-13 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | S - Sale | $82.47 | -1,180 | 55.1K | -2% | -$97.3K | |
| M | 2022-03-31 | 2022-03-29+ | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | S - Sale | $79.49 | -2,999 | 57.6K | -5% | -$238.4K |
| M | 2022-03-24 | 2022-03-22+ | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | S - Sale | $81.58 | -8,202 | 65.4K | -11% | -$669.1K |
| D | 2022-03-17 | 2022-03-15 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | A - Grant | $0.00 | +11.9K | 77.2K | +18% | $0 |
| DM | 2022-03-17 | 2022-03-15+ | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | F - Tax | $78.59 | -9,705 | 68.7K | -12% | -$762.8K |
| 2022-03-10 | 2022-03-08 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | A - Grant | $0.00 | +9,370 | 65.2K | +17% | $0 | |
| 2021-10-28 | 2021-10-26 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | S - Sale | $73.60 | -2,739 | 55.9K | -5% | -$201.6K | |
| 2021-10-28 | 2021-04-30 | BMRN | BIOMARIN PHARMACEUTICAL INC | Ajer Jeffrey Robert | EVP, Chief Commercial Off | A - Grant | $62.41 | +342 | 58.6K | +0.6% | +$21.3K | |
| D | 2021-09-24 | 2021-09-22 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Dir | S - Sale | $17.78 | -3,665 | 32.5K | -10% | -$65.2K |
| D | 2021-09-24 | 2021-09-22 | NKTR | NEKTAR THERAPEUTICS | Ajer Jeffrey Robert | Dir | A - Grant | $0.00 | +10.2K | 36.2K | +39% | $0 |
Purchase Sale Sale after option exercise All abbreviations